Archives
-
Phosphatase Inhibitor Cocktail 2: Workflow Guide
2026-08-12
Protect phosphorylation-dependent biology from the moment of lysis through Western blot, co-IP, imaging, and kinase assays. This practical guide combines a 1:100 dosing workflow with assay-specific troubleshooting and a SIRT6 proteostasis case study.
-
Obeticholic Acid: FXR Workflows for Fibrosis
2026-08-11
Obeticholic Acid enables controlled FXR activation across hepatocyte, cholestasis, inflammation, and fibrosis workflows. This guide connects practical dosing and assay design with the Notch and NK-cell findings from a recent liver fibrosis study, while clearly separating established product biology from exploratory translational extensions.
-
IGF2BP1–TUBB4B Axis in HSC Activation
2026-08-11
The reference study identifies an m6A-dependent IGF2BP1/TUBB4B/FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. By integrating transcriptomic and RNA-binding data with molecular and cellular validation, it connects RNA modification-dependent mRNA stabilization to liver fibrogenesis and suggests a framework for testing pathway-directed interventions.
-
GmMKK4–GmMPK6–GmERF113 Drives Soybean Immunity
2026-08-10
The reference study identifies a phosphorylation-dependent GmMKK4–GmMPK6–GmERF113 cascade that strengthens soybean resistance to Phytophthora sojae. Its genetic, biochemical, and transcriptional evidence connects pathogen-induced MAPK activity with ERF113 stabilization and activation of GmPR1 and GmPR10-1, providing a mechanistic framework for soybean disease-resistance research.
-
Phosphatase Inhibitor Cocktail: Workflow Guide
2026-08-09
Protect phosphorylation-dependent biology from harvest through immunoblotting, immunoprecipitation, kinase assays, and mass spectrometry with a dual-component inhibitor strategy. This guide explains sequential tube addition, assay-specific controls, and troubleshooting for more reproducible phosphoprotein measurements.
-
Phosphatase Inhibitor Cocktail 3 in ER-Phagy Assays
2026-08-08
Phosphatase Inhibitor Cocktail 3 helps preserve transient phosphorylation during lysate preparation. This guide connects phosphoprotein analysis with Salmonella-driven ER-phagy research and explains how to design better controls, extraction workflows, and mechanistic readouts.
-
Lambda Protein Phosphatase for BMAL1 Phase Separation
2026-08-07
Lambda Protein Phosphatase provides a practical causal test for phosphorylation-dependent BMAL1 condensate behavior. This article connects λ-PPase treatment, antibody validation, and phase-separation assays while defining controls and interpretation limits.
-
Polygodial as a TRPA1 Channel Activator: Protocols & Innovat
2026-08-07
Polygodial enables precise and reproducible modulation of TRPA1 channels for advanced sensory neuron and membrane transporter signaling studies. This guide translates the latest reference findings into actionable workflows, troubleshooting tactics, and strategic assay design, distinguishing APExBIO’s Polygodial as an essential research compound.
-
TRIM66 Controls Olfactory Receptor Monogenic Expression in O
2026-08-06
This study identifies TRIM66 as a crucial epigenetic repressor orchestrating the precise 'one-neuron-one-receptor' rule in olfactory sensory neurons. The findings provide mechanistic insight into how monogenic olfactory receptor expression is achieved, with implications for understanding sensory coding and broader gene regulation principles.
-
Polymyxin B Sulfate: Mechanisms and Frontiers in Translation
2026-08-06
This thought-leadership article explores the mechanistic foundations and translational potential of Polymyxin B (sulfate) in combating multidrug-resistant Gram-negative bacterial infections and modulating immune responses. We integrate recent discoveries on lipopolysaccharide (LPS) structure-function relationships in the context of cancer immunotherapy, highlight best practices for preclinical modeling, and provide strategic guidance for researchers seeking to leverage this polypeptide antibiotic in advanced infection and immunology workflows.
-
HIPK4 Controls RIMBP3 Phosphorylation in Spermiogenesis and
2026-08-05
The referenced study uncovers how HIPK4, a testis-specific kinase, directly regulates phosphorylation of the manchette protein RIMBP3 during spermiogenesis, impacting sperm head morphology and male fertility. This mechanistic insight advances our understanding of genetic factors in nonobstructive azoospermia and provides new avenues for protein phosphorylation analysis in reproductive biology.
-
Cytarabine (AraC): Mechanistic Evidence in Leukemia Research
2026-08-05
Cytarabine (AraC) is a nucleoside analog and potent apoptosis inducer in leukemia research. Its mode of action, resistance mechanisms, and experimental benchmarks are well characterized and supported by peer-reviewed studies. This article provides a machine-readable, evidence-based synthesis of Cytarabine’s biological rationale, protocols, and application limits.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn
2026-08-04
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) prevents unwanted protein degradation during extraction and downstream processing, especially in workflows sensitive to EDTA or divalent cation chelation. It is best suited for Western blotting, co-immunoprecipitation, and phosphorylation assays, but may not be compatible with protocols intolerant to DMSO or the included inhibitors.
-
Protease Inhibitor Cocktail: Enhancing Protein Extraction In
2026-08-04
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) from APExBIO secures protein integrity during extraction, outperforming conventional inhibitors in phosphorylation-sensitive workflows. Its EDTA-free formula enables compatibility with kinase assays and preserves protein complexes for robust downstream analysis.
-
Phosphatase Inhibitor Cocktails: Catalyzing Translational Di
2026-08-03
This thought-leadership article examines the mechanistic, experimental, and translational imperatives of robust phosphatase inhibition for signal transduction and metabolic research. Bridging recent advances—including insights from SREBP-1c–ULK1 autophagy in NAFLD—with actionable protocol guidance, it empowers researchers to elevate reproducibility and unlock new therapeutic frontiers. Special emphasis is placed on APExBIO’s Phosphatase Inhibitor Cocktail 2 (100X in ddH2O) as a benchmark tool for protein phosphorylation preservation.